MedBen Rx
  • About Us
  • Genomic Testing
  • Resources
    • MedBen Rx Blog
    • Online Services & Forms
  • Contact Us
  • MedBen Access
  • MedBen.com
Select Page

AWP Smoke and Mirrors

Dec 21, 2018 | Average Wholesale Price, MedBen Rx, Pharmacy Benefits Manager (PBM), Rx Costs, Savings

Drug pricing can be a confusing business… and much of the confusion stems from a drug’s average wholesale price, or AWP. On the surface, the AWP might seem to be… well, the average wholesale price or the average price of a drug. But the price to who? As...

MedBen Rx Tackles Brand-Name Increases

Dec 2, 2018 | Brand Name Drugs, Generic Drugs, MedBen Rx, MedBen Rx Advocate, MedBen Rx Alliance, Pharmacy Benefits Manager (PBM), Specialty Drugs

Modern Healthcare recently highlighted the growing disparity between brand-names and generics in relation to prescription drug spending. A new study finds that while total spending on generic drugs has declined, branded prescription drug spending continues to rise. In...

The Clear Solution to Rx Spending Trends

Nov 21, 2018 | MedBen Rx, Rebates, Rx Costs, Rx Spending, Savings, Specialty Drugs

A New York Times article examines the dramatic rise in U.S. prescription drug costs over the past two decades. American drug spending was once on par with other wealthy countries, but between 1997 and 2007 our drug spending tripled… and took off again in 2013....

Generic Drugs: Effective and Cost-Efficient

Nov 6, 2018 | Generic Drugs, MedBen Rx, Rx Costs, Savings

As the prescribing of generic drugs has become more commonplace, most consumers have come to see that these medications work just as well as their pricier band-name equivalents. Indeed, when a generic alternative is available, MedBen clients see a 98% average...

MedBen Rx Solutions Put Transparency Up Front

Oct 23, 2018 | Legislation, MedBen Access, MedBen Rx, Online Services, Rebates, Rx Costs, Transparency

In an effort to improve drug pricing transparency, the Department of Health and Human Services recently released a proposal requiring drug companies to include their list prices in consumer ads. But MedBen already provides far more transparent Rx solutions. Drug...
« Older Entries
Next Entries »

Categories

  • 340B
  • Access solution
  • Access solutions
  • Acquisition Cost Index (ACI)
  • Affordable Care Act
  • Anniversaries
  • Announcements
  • Appropriateness Solutions
  • Avande
  • Average Wholesale Price
  • Benefits Advisory Conference
  • Benefits preservation
  • Biologics
  • Biosimilar
  • Brand Name Drugs
  • Brian Fargus
  • Cancer
  • Caroline Fraker
  • Case Study
  • Cholesterol
  • Claims
  • Client Report
  • Comparative Effectiveness
  • Compliance
  • Consolidated Appropriations Act of 2021 (CAA)
  • Cost Plus
  • Cost Plus Pricing
  • Cost projections
  • Cost Savings
  • Diabetes
  • Discounts
  • Doug Freeman
  • Drug costs
  • Drug makers
  • Drug marketing
  • Drug reimportation
  • Evidence-based research
  • Federal Trade Commission (FTC)
  • Food and Drug Administration (FDA)
  • Formularies
  • Fraud
  • Gene therapy
  • Generic Drugs
  • Genetic testing
  • Genomics
  • GLP-1s
  • Government
  • Guarantees
  • Health and Human Services
  • Health systems
  • Heart medications
  • History
  • Humalog
  • Humira
  • Idacio
  • Inflation
  • Kurt Harden
  • Lawsuits
  • Legislation
  • Limited Use HRA
  • Lobbying
  • Luke Burchard
  • MDMA (ecstasy)
  • MedBen
  • MedBen Access
  • MedBen Basics
  • MedBen Board of Directors\
  • MedBen employees
  • MedBen Rx
  • MedBen Rx Advocate
  • MedBen Rx Alliance
  • MedBen Rx News
  • MedBen University
  • Medicare
  • Mobile app
  • Mounjaro
  • News
  • Nutrigenomics
  • Online Services
  • Opinions
  • Outcomes
  • Overprescribing
  • Own Use
  • Ozempic
  • Patient advocacy program
  • Perigon Pharmacy 360
  • Pharmacies
  • Pharmacogenomics
  • Pharmacy Benefits Manager (PBM)
  • Pharmacy Services Administrator (PSA)
  • Precision medicine
  • Prescription drugs
  • Prescription Portal
  • Pricing solutions
  • Psychedelic drugs
  • Rebates
  • Regulatory
  • Reporting
  • Research
  • Rx Advertising
  • Rx Costs
  • Rx Facts
  • Rx prices
  • Rx Spending
  • RxDC report
  • Savings
  • Specialty Drugs
  • Spread Pricing
  • State legislation
  • Statins
  • Stelara
  • Study
  • Surveys
  • Transparency
  • Trend
  • TruDataRx
  • Trulicity
  • Value
  • Ventegra
  • Wegovy
  • Weight loss
  • Weight loss drugs
  • Weight management
  • Wellness
  • White paper
  • Zepbound
  • About Us
  • Contact Us
  • Blog
  • Online Services
  • MedBen Access
  • Sitemap
  • Privacy
  • MedBen.com

Sign Up for our Newsletter

  • This field is for validation purposes and should be left unchanged.
© 2025 MedBen Rx. All rights reserved.